Social interaction and drug attitude effectiveness in patients with schizophrenia
- PMID: 21499787
- DOI: 10.1007/s11126-011-9177-z
Social interaction and drug attitude effectiveness in patients with schizophrenia
Abstract
This study aimed to explore the relationship between dosage of paliperidone and drug attitude, and also clarify the factors associated with drug attitude, using Intention-to-Treat (ITT) analysis. Three hundred thirty-one patients diagnosed with schizophrenia, who prescribed paliperidone between April 2008 and April 2009, from 10 hospitals in Taiwan were enrolled. By structural equation modeling, inpatient/outpatient status associated with occupation status, sex, and score on the Clinical Global Impression-Severity (CGIS) Scale. The score on the Personal and Social Performance (PSP) Scale associated with occupation status, inpatient/outpatient status, and the score on the CGIS Scale. The scores on the DAI-10 associated with the score on the PSP Scale and age. Good drug attitude and medication adherence significantly related to good social interaction. We should enhance the drug attitude and medication adherence of patients with schizophrenia who have poor social interaction to improve the outcome of schizophrenia.
Similar articles
-
The effect of paliperidone extended release on subjective well-being and responses in patients with schizophrenia.Prog Neuropsychopharmacol Biol Psychiatry. 2012 Aug 7;38(2):228-35. doi: 10.1016/j.pnpbp.2012.04.004. Epub 2012 Apr 10. Prog Neuropsychopharmacol Biol Psychiatry. 2012. PMID: 22516251
-
Clinical effectiveness and resource utilization of paliperidone ER for schizophrenia: Pharmacoepidemiologic International Longitudinal Antipsychotic Registry (PILAR).Curr Med Res Opin. 2014 Jul;30(7):1279-89. doi: 10.1185/03007995.2014.898630. Epub 2014 Mar 19. Curr Med Res Opin. 2014. PMID: 24597755
-
Reliability, validity and ability to detect change of the clinician-rated Personal and Social Performance scale in patients with acute symptoms of schizophrenia.Curr Med Res Opin. 2009 Feb;25(2):325-38. doi: 10.1185/03007990802611919. Curr Med Res Opin. 2009. PMID: 19192977
-
Extended-release paliperidone: efficacy, safety and tolerability profile of a new atypical antipsychotic.Drugs Today (Barc). 2007 Apr;43(4):249-58. doi: 10.1358/dot.2007.43.4.1067342. Drugs Today (Barc). 2007. PMID: 17460786 Review.
-
Paliperidone extended release: in adolescents with schizophrenia.Paediatr Drugs. 2012 Dec 1;14(6):417-27. doi: 10.2165/11209900-000000000-00000. Paediatr Drugs. 2012. PMID: 23050744 Review.
Cited by
-
Critical evaluation of paliperidone in the treatment of schizophrenia in Chinese patients: a systematic literature review.Neuropsychiatr Dis Treat. 2016 Jan 11;12:113-31. doi: 10.2147/NDT.S64672. eCollection 2016. Neuropsychiatr Dis Treat. 2016. PMID: 26811684 Free PMC article. Review.
-
Reliability and Validity of the Short Version of Udvalg for Kliniske Undersogelser in Antipsychotic Treatment.Psychiatr Q. 2017 Dec;88(4):787-796. doi: 10.1007/s11126-017-9494-y. Psychiatr Q. 2017. PMID: 28150091
-
Correlates of Negative Attitudes towards Medication in People with Schizophrenia.Psychiatr Q. 2019 Mar;90(1):159-169. doi: 10.1007/s11126-018-9618-z. Psychiatr Q. 2019. PMID: 30478641
-
Factors Affecting Well-being and Socio-occupational Functioning in Schizophrenia Patients Following an Acute Exacerbation: A Hospital Based Observational Study.Indian J Psychol Med. 2015 Oct-Dec;37(4):423-8. doi: 10.4103/0253-7176.168585. Indian J Psychol Med. 2015. PMID: 26702175 Free PMC article.
-
Translation and validation of the “personal evaluation of transitions in treatment (PETIT)” scale for people with schizophrenia.Actas Esp Psiquiatr. 2022 Jan;50(1):27-41. Epub 2022 Jan 1. Actas Esp Psiquiatr. 2022. PMID: 35103295 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous